Mrv0541 02231215552D 8 8 0 0 0 0 999 V2000 -0.1467 2.3518 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.5678 1.9393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2822 2.3518 0.0000 N 0 3 0 0 0 0 0 0 0 0 0 0 0.5678 1.1143 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.2352 0.6294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9803 -0.1553 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.1553 -0.1553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0997 0.6294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 2 0 0 0 0 2 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 2 0 0 0 0 6 7 1 0 0 0 0 7 8 2 0 0 0 0 4 8 1 0 0 0 0 M CHG 1 3 1 M END > DB02048 > drugbank > NC(=[NH2+])N1C=NC=N1 > InChI=1S/C3H5N5/c4-3(5)8-2-6-1-7-8/h1-2H,(H3,4,5)/p+1 > CDIOIIJXUJXYPB-UHFFFAOYSA-O > C3H6N5 > 112.1132 > 112.062320217 > 3 > 14 > 0.9166934111857692 > 10.236349117535164 > 1 > 2 > 1 > 0 > [amino(1H-1,2,4-triazol-1-yl)methylidene]azanium > -0.30 > -1.2954647446666665 > -1.04 > 0 > 1 > 1 > 1 > 8.041540670767434 > 82.32000000000001 > 50.875499999999995 > 0 > 1 > 1.35e+01 g/l > tetrahydrofolic acid > 0 > DB02048 > EXPT03150 > experimental > 1,2,4-Triazole-Carboxamidine $$$$